What are the definition, epidemiology, risk factors, clinical presentation, physical examination findings, laboratory and imaging studies, classification, and management of osteomyelitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Osteomyelitis: Comprehensive Overview

Definition

Osteomyelitis is an inflammatory disease of bone caused by bacterial infection, characterized by the presence of inflammatory cells, bone necrosis, and isolation of bacteria from an aseptically obtained bone sample 1. The definitive diagnosis requires both histological findings (acute or chronic inflammatory cells, necrosis) and positive bacterial cultures from bone 1.


Epidemiology and Risk Factors

Epidemiology

  • Found in approximately 50-60% of hospitalized patients with diabetic foot infections and 10-20% of less severe ambulatory infections 1
  • Typically involves the forefoot (less often hindfoot) and develops by contiguous spread from overlying soft tissue 1
  • In pediatric populations, hematogenous seeding primarily affects metaphyses of long bones, with >50% of cases occurring in children ≤5 years old 2

Risk Factors

Medical History Factors (strongest predictors):

  • History of foot ulcers/foot disease (OR = 2.52) 3
  • Operation duration >3 hours (OR = 1.74) 3
  • Incision length >10 cm (OR = 6.53) 3
  • Diabetes mellitus with poor glycemic control 1
  • Peripheral artery disease 4
  • Immunosuppression 5
  • Intravenous drug use 6

Clinical Features Associated with Higher Risk:

  • Inflamed ulcer (OR = 6.20) 3
  • Fever (OR = 2.20) 3
  • Ulcer size >4-5 cm² (OR = 2.74) 3
  • Ulcer overlying bony prominence 1

Laboratory Findings:

  • Elevated HbA1c (OR = 1.14) 3
  • Hypoalbuminemia (OR = 1.74) 3
  • Anemia (OR = 1.54) 3

Microbiological Factors:

  • Polymicrobial infections (OR = 2.58) 3

Clinical Presentation (Symptoms)

Key Clinical Features to Assess:

For Diabetic Foot Osteomyelitis:

  • Pain at the affected site (though may be diminished with neuropathy) 1
  • Ulcer that fails to heal despite adequate off-loading 1
  • "Sausage toe" appearance (erythematous and indurated digit) 1
  • Local swelling or induration 1
  • Purulent discharge 1
  • Fever (present in <80% of cases) 7

Important Note: Osteomyelitis can occur in the absence of overlying local signs of inflammation 1.

Systemic Signs (indicating severe infection):

  • Temperature >38°C or <36°C 1
  • Heart rate >90 beats/min 1
  • Respiratory rate >20 breaths/min 1
  • White blood cell count >12,000/mm³ or <4,000/mm³ 1

Physical Examination Findings

Critical Examination Components:

Probe-to-Bone Test (most important clinical tool):

  • Perform this test on all infected open wounds 1
  • Use a blunt sterile metal probe gently inserted through the wound
  • Positive test: probe strikes bone with hard, gritty feel
  • In high-risk patients (>60% prevalence), positive test is largely diagnostic (positive LR 7.2) 1
  • In low-risk patients (≤20% prevalence), negative test essentially rules out osteomyelitis (negative LR 0.48) 1

Wound Assessment:

  • Exposed bone visible in wound (positive LR 9.2) 1
  • Ulcer area >2 cm² (positive LR 7.2) 1
  • Erythema extending >0.5 cm around wound 1
  • Local tenderness and warmth 1

Joint Assessment:

  • Limited mobility (especially in septic arthritis) 7
  • Joint effusion 5

Laboratory Findings

Inflammatory Markers:

Erythrocyte Sedimentation Rate (ESR):

  • Markedly elevated ESR is suggestive of osteomyelitis 1
  • ESR is the only laboratory parameter significantly correlated with both positive culture results and longer hospitalization 7
  • Elevated in 52.6% of osteomyelitis patients 7

C-Reactive Protein (CRP):

  • Elevated in 68.4% of osteomyelitis patients 7
  • Use when clinical examination is diagnostically equivocal 4

Procalcitonin (PCT):

  • Consider assessing when diagnosis is uncertain 4

Complete Blood Count:

  • Leukocytosis present in 57.9% of osteomyelitis patients 7
  • Less sensitive than inflammatory markers

Microbiological Studies:

Blood Cultures:

  • Positive in only 23.1% of osteomyelitis patients 7
  • Staphylococcus aureus most common organism (75% of positive cultures) 7

Bone Cultures (gold standard):

  • Obtain bone samples (not soft tissue) for culture when diagnosis is uncertain or antibiotic susceptibilities are needed 4
  • Use conventional (not molecular) microbiology techniques for first-line identification 4
  • Avoid using soft tissue or sinus tract specimens for selecting antibiotic therapy as they do not accurately reflect bone culture results 1
  • Obtain intraoperatively or percutaneously 4

Common Pathogens:

  • S. aureus (~50% of cases) 1
  • Coagulase-negative staphylococci (~25%) 1
  • Aerobic streptococci (~30%) 1
  • Enterobacteriaceae (~40%) 1

Radiological Findings

Diagnostic Algorithm:

Step 1: Plain Radiographs (initial study for all cases):

  • Obtain plain radiographs in all cases of non-superficial infection 1
  • Sensitivity: 54%, Specificity: 68% 8
  • Early osteomyelitis (<14 days): radiographs may be normal or show only soft tissue swelling 5
  • Classic findings (when present, treat for presumptive osteomyelitis):
    • Cortical erosion 9
    • Active periosteal reaction 9
    • Mixed lucency and sclerosis 9
  • If initial radiographs are negative but suspicion persists, repeat in 2-4 weeks 9

Step 2: Advanced Imaging When Needed:

MRI (imaging modality of choice):

  • Use MRI when diagnosis remains in doubt despite clinical, plain radiographs, and laboratory findings 4
  • MRI has 100% negative predictive value; normal marrow signal reliably excludes infection 2
  • Positive findings: decreased T1-weighted bone marrow signal with increased signal on fluid-sensitive sequences 2
  • Superior for detecting early osteomyelitis and defining extent of soft tissue involvement 9
  • Not always necessary if plain radiographs show classic changes and clinical picture is clear 9

Alternative Imaging (when MRI unavailable or contraindicated):

  • White blood cell-labeled radionuclide scan 1
  • SPECT/CT 4
  • PET scan 4
  • Ultrasound (useful for detecting joint effusions, especially hip) 10

Classification

IWGDF/IDSA Classification System 1:

Grade 1 (Uninfected):

  • No systemic or local symptoms/signs of infection

Grade 2 (Mild Infection):

  • Infection involving only skin or subcutaneous tissue
  • Erythema extends <2 cm around wound
  • No systemic signs

Grade 3 (Moderate Infection):

  • Infection involving deeper structures (bone, joint, tendon, muscle)
  • OR erythema extending ≥2 cm from wound margin
  • No systemic signs

Grade 4 (Severe Infection):

  • Any foot infection with systemic inflammatory response syndrome (≥2 criteria):
    • Temperature >38°C or <36°C
    • Heart rate >90 beats/min
    • Respiratory rate >20 breaths/min
    • WBC >12,000/mm³ or <4,000/mm³ or >10% immature forms

Treatment

Antibiotic Therapy:

Duration Based on Infection Site 4, 8:

Soft Tissue Only:

  • 1-2 weeks of antibiotic therapy 4
  • May extend up to 3-4 weeks if infection is extensive, improving slowly, or patient has severe peripheral artery disease 4
  • If no resolution after 4 weeks, re-evaluate and reconsider diagnosis or alternative treatments 4

Bone or Joint Involvement:

  • 4-6 weeks of antibiotic therapy 8
  • Initial parenteral therapy, then consider oral switch when clinically appropriate 8

Antibiotic Selection:

  • Base selection on culture results and antibiotic susceptibilities 4
  • Use bone culture-guided therapy when possible (significantly better outcomes: 56.3% vs 22.2% success) 8
  • Use any systemic antibiotic regimen shown effective in published RCTs at standard dosing 4
  • Consider published efficacy for diabetic foot infections, adverse event risk, and collateral damage to commensal flora 4

Key Principle: Do NOT treat clinically uninfected foot ulcers with antibiotics to reduce infection risk or promote healing 4

Surgical Management:

Indications for Surgery:

  • Exposed grossly infected bone 8
  • Septic joint (immediate surgical debridement required due to 70% bacteremia risk) 6
  • Deep soft tissue abscesses 2
  • Failed medical therapy 9

Bone Biopsy Indications 8:

  • Uncertainty regarding diagnosis despite clinical and imaging evaluations
  • Absence or confusing mix of culture data from soft tissue specimens
  • Infection failed to respond to initial empirical therapy
  • When considering antibiotic regimen with higher potential for selecting resistant organisms

Hospitalization Criteria 4:

Consider hospitalizing patients with:

  • Severe foot infection (Grade 4)
  • Moderate infection (Grade 3) with key relevant morbidities

Adjunctive Measures:

  • Adequate off-loading of affected area 1
  • Optimization of vascular status 11
  • Glycemic control in diabetic patients 1
  • Wound care 9

Common Pitfalls and Caveats:

  1. Do not rely on normal radiographs to exclude early osteomyelitis - changes may take weeks to appear 8
  2. Do not use soft tissue or sinus tract cultures to guide osteomyelitis antibiotic therapy - they do not accurately reflect bone pathogens 1
  3. Do not continue antibiotics until wound healing - stop when infection resolves 8
  4. Distinguish Charcot neuro-osteoarthropathy from osteomyelitis - Charcot typically affects midfoot, occurs with profound neuropathy, and usually lacks skin break 1
  5. Probe-to-bone test interpretation depends on pretest probability - most useful in intermediate-risk patients 9
  6. MRI may be difficult to interpret with orthopedic hardware due to metal artifact 2

References

Research

Risk factors for osteomyelitis: a systematic review and meta-analysis.

International journal of surgery (London, England), 2025

Guideline

diagnosis and treatment of diabetic foot infections.

Clinical Infectious Diseases, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.